logo
Plus   Neg
Share
Email

Roche Announces FDA Approval For Expanded Use Of Venclexta - Quick Facts

Roche (RHHBY.PK) reported FDA approval for Venclexta plus Gazyva for the treatment of people with previously untreated chronic lymphocytic leukaemia. The FDA previously granted Breakthrough Therapy Designation for the combination. The company said the approval for expanded use of Venclexta offers more adults with chronic lymphocytic leukaemia a new treatment option.

Venclexta is being developed by AbbVie and Roche. It is jointly commercialised by AbbVie and Genentech, a member of the Roche group, in the US and commercialised by AbbVie outside of the US.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
International Business Machines Corp. and Cúram Software, acquired by the tech giant in 2011, have agreed to pay $14.8 million to settle alleged violations of the False Claims Act, the Justice Department said in a statement. According to the DOJ, IBM and Cúram allegedly made material misrepresentations to the State of Maryland during a contract award process in 2011 and 2012. Lyrics website Genius Media Group Inc. has accused Google of copying some song lyrics directly from its website without permission, for the tech giant's search results. Genius told the Wall Street Journal that it is seeing falling traffic for the past several years as Google has been publishing lyrics in search pages on its own platform, with some of them lifted directly from the Genius website. CVS is planning to invest $10 million to create awareness among youth against the ill effects of e-cigarette. Over a period of next five year, the foundation would invest $50 million, aiming to achieve "nation's first tobacco-free generation." The "Be The First" campaign will also partner with American...
Follow RTT